Long-term vision gain after PhotoDynamic Therapy of Choroidal NeoVascularisations in pediatric and young adult patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN24428087

Enrollment

Registered

2007-06-22

Start date

1999-08-01

Completion date

Unknown

Last updated

2021-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Choroidal neovascularization in younger patients Eye Diseases Choroidal neovascularization

Interventions

Photodynamic therapy with verteporfin (Visudyne). An infusion of verteporfin (for 10 minutes) and laser application to the retina in one study eye (83 seconds) was performed. There was no treatment of

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients below age 30 2. Vision-limiting choroidal neovascularisation

Exclusion criteria

Exclusion criteria: Previous (laser) treatment.

Design outcomes

Primary

Measure	Time frame
1. Visual acuity 2. Lesion size Mean follow-up of 34.4 months.	—

Secondary

Measure	Time frame
Application number (per year). Mean follow-up of 34.4 months.	—

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026